Insider Transactions in Q4 2024 at Rxo, Inc. (RXO)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2024
|
Andrew M. Wilkerson Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,090
-0.76%
|
$25,070
$23.84 P/Share
|
|
Dec 31
2024
|
Andrew M. Wilkerson Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,213
+1.51%
|
-
|
|
Dec 31
2024
|
S Jacobs Bradley Director |
SELL
Payment of exercise price or tax liability
|
Direct |
544,261
-34.05%
|
$12,518,003
$23.84 P/Share
|
|
Dec 31
2024
|
S Jacobs Bradley Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,174,495
+42.36%
|
-
|
|
Nov 14
2024
|
Andrew M. Wilkerson Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
689
-0.48%
|
$18,603
$27.49 P/Share
|
|
Nov 14
2024
|
Andrew M. Wilkerson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,566
+1.09%
|
-
|
|
Nov 12
2024
|
Michelle Nettles Director |
BUY
Open market or private purchase
|
Direct |
1,800
+10.6%
|
$48,600
$27.89 P/Share
|
|
Oct 03
2024
|
Jason S. Kerr Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,153
-3.68%
|
$85,131
$27.07 P/Share
|